PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.61%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-80.85%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-97.57%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-97.57%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-38.74%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-37.50%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-37.50%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-13.82%
Share reduction while ADI is at 0.65%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-13.82%
Reduced diluted shares while ADI is at 0.65%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
39.67%
10Y revenue/share CAGR 1.25-1.5x ADI's 29.59%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
39.67%
5Y revenue/share CAGR 1.25-1.5x ADI's 29.59%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
34.10%
3Y revenue/share CAGR 1.25-1.5x ADI's 29.59%. Bruce Berkowitz might see better product or regional expansions than the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
184.89%
10Y net income/share CAGR of 184.89% while ADI is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
184.89%
Net income/share CAGR of 184.89% while ADI is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
405.40%
3Y net income/share CAGR of 405.40% while ADI is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.00%
3Y dividend/share CAGR of 8.00% while ADI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.